NCT02981173 - Psilocybin for the Treatment of Cluster Headache | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 5, 2016

Primary Completion Date

June 30, 2022

Study Completion Date

October 21, 2022

Conditions

Cluster Headache

Interventions

DRUG

0.143 mg/kg Psilocybin or 10 mg Psilocybin

0.143 mg/kg psilocybin capsule (weight-based option) or 10 mg psilocybin capsule (fixed-dose option) ingested on each of three test days (5 days apart +/- 1-2 days)

DRUG

0.0143 mg/kg Psilocybin or 1 mg Psilocybin

0.0143 mg/kg psilocybin capsule (weight-based option) or 1 mg psilocybin (fixed-dose option) ingested on each of three test days (5 days apart +/- 1-2 days)

DRUG

Placebo

Microcrystalline cellulose capsule ingested on each of three test days (5 days apart +/- 1-2 days)

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven